SOLV241220P70000
- 1.30
- 0.000.00%
Solventum Newsroom
Morgan Stanley Lists Hedge Funds' Largest Q3 Ownership Increases in Russell 1000 Stocks
Solventum to Participate in the Piper Sandler Healthcare Conference
Trian Fund Management 13F Shows Added Stake In Solventum Corp From 5,360,579 To 7,126,255 Shares; Increased Stake In Janus Henderson Group By 13% From 1,074,263 To 1,213,207 Shares; Increased Stake In General Electric Co. By 19% From 640,682 To...
Express News | Corrected-Brief-(Official)-Trian Fund Management Cuts Share Stake in Allstate (Nov. 13)
Express News | Corrected-(Official)-Trian Fund Management Has Stake of 57.1 Mln Shares (Not 'dissolves Share Stake') in Rentokil
Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment
Trian Exits Disney, Rentokil Among Q3 Moves, Almost Entirely Sheds GE HealthCare
Express News | Trian Fund Management LP - Change in Holdings Are as of September 30, 2024 and Compared With the Previous Quarter Ended as of June 30, 2024
Express News | Trian Fund Management, L.p. Raises Share Stake in Solventum Corporation by 32.9% to 7.1 Mln Shares
Is Solventum (NYSE:SOLV) A Risky Investment?
Critical Insights From Solventum Analyst Ratings: What You Need To Know
Stifel Maintains Solventum(SOLV.US) With Buy Rating, Maintains Target Price $82
Morgan Stanley Maintains Solventum(SOLV.US) With Hold Rating, Raises Target Price to $73
Express News | Solventum Corp : Morgan Stanley Raises Target Price to $73 From $60
Solventum Third Quarter 2024 Earnings: Beats Expectations
Assessing MedTech Impact From Potential China Tariffs
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight
Solventum Corporation (SOLV) Q3 2024 Earnings Call Transcript Summary
Solventum | 10-Q: Q3 2024 Earnings Report
BofA Securities Maintains Solventum(SOLV.US) With Hold Rating, Maintains Target Price $80